LUMI PRO Skin Booster – Triple Pack (3 x 2ml)

LUMI PRO Skin Booster – Triple Pack (3 x 2ml)

LUMI-PRO

Medical Device
  • Marketed in the UK and EU as a professional Use injectable hyaluronic acid skin booster under the Lumifil/LUMI PRO brand, with CE Marked medical device classification referenced by distributors.
  • Manufactured under ISO 13485 Compliant quality management systems for medical devices by BNC Korea, a recognised manufacturer of aesthetic injectables.
  • Intended strictly for professional administration in accordance with local medical device regulations and professional practice standards governing cosmetic injectables.
Injectable Hyaluronic Acid Skin Booster

Description

LUMI-PRO Skin Booster Triple Pack is a state-of-the-art injectable skin hydrating treatment designed to deliver intense hydration, promote collagen stimulation and give an effortless glow. Developed by UK Skin-Tech Innovation under the Lumifil/LUMI-PRO brand and manufactured by BNC Korea, this advanced non-crosslinked hyaluronic acid (HA) skin booster is formulated for use on the face, hands and neck. With a market-leading concentration of 40 mg of ultra high-purity HA per 2 ml (20 mg/ml), LUMI-PRO penetrates the deeper layers of the skin to hydrate, firm and tighten while enhancing texture and radiance. Results can be seen in as little as 48 hours for many patients. Supplied as a premium triple pack of 3 x 2 ml pre-filled syringes, it offers a versatile and cost-effective option for total skin rejuvenation in professional aesthetic practice.

Bnefits

  • Delivers intense, instant hydration with a market-leading 40 mg hyaluronic acid per 2 ml (20 mg/ml) concentration.
  • Deeply hydrates the dermal layers, improving skin plumpness, softness and overall comfort.
  • Promotes collagen stimulation, helping to improve skin firmness, elasticity and vitality.
  • Designed specifically for use on the face, hands and neck, allowing comprehensive treatment of key visible areas.
  • Helps to firm and tighten the skin, smoothing the appearance of fine lines and early wrinkles.
  • Enhances skin texture and tone, contributing to a smoother, more even and refined surface.
  • Restores a healthy glow and radiance, providing “total hydration in a syringe.”
  • Ultra high-purity HA for smooth application and consistent injection characteristics.
  • Premium triple pack (3 x 2 ml) design offers excellent value, being around 33% cheaper than many comparable triple-pack boosters according to brand claims.
  • Visible improvements often reported within approximately 48 hours post-treatment, depending on individual factors.

Indications

  • Professional injectable skin booster treatment for dehydrated, dull or tired-looking skin on the face, hands and neck.
  • Patients seeking enhanced skin hydration and glow without the volumising effect of traditional crosslinked dermal fillers.
  • Early to moderate photoageing or chronoageing presenting as fine lines, reduced firmness, mild laxity or uneven texture.
  • Skin requiring improvement in overall tone, radiance and suppleness as part of an anti-ageing or skin quality protocol.
  • Adjunct to other aesthetic treatments (e.g. neuromodulators, energy-based devices, peels) to improve skin quality and hydration.
  • Suitable for a wide range of adult patients, as determined by a qualified practitioner, looking for non-surgical skin rejuvenation.

Composition

  • Active ingredient: Hyaluronic acid 20 mg/ml (40 mg per 2 ml syringe), non-crosslinked, ultra high purity.
  • Vehicle: Sterile, buffered aqueous solution suitable for intradermal injection (full excipient list proprietary to manufacturer but typically includes physiological salts and stabilisers).
  • No added lidocaine (according to distributor descriptions, unless stated otherwise on specific regional packaging).
  • Free from crosslinking agents used in volumising fillers; formulated as a skin hydrating booster rather than a structural filler.

Formulation

  • Product type: Injectable non-crosslinked hyaluronic acid skin hydrating booster.
  • Pharmaceutical form: Sterile, clear, viscoelastic solution in pre-filled glass or plastic syringes.
  • Concentration: 40 mg HA per 2 ml (20 mg/ml).
  • Volume: 2 ml per syringe.
  • Route of administration: Intradermal or very superficial sub-dermal injection by licensed healthcare or aesthetic professionals only.
  • Treatment areas: Face, hands and neck.
  • Mode of action: Deep hydration and collagen stimulation leading to firmer, smoother and more radiant skin.

Packaging

  • Pack contains: 3 x 2 ml pre-filled syringes (total 6 ml) of LUMI-PRO Skin Booster.
  • Each syringe is individually sterile-packed (e.g. in blister/tray) within a premium outer carton.
  • Outer carton clearly indicates brand (LUMI-PRO), product name (Skin Booster), HA content (40 mg/2 ml), pack size (3 x 2 ml), intended use (professional only), batch number, and expiry date.
  • Some distributors (e.g. Two Face Aesthetics) reference internal product code TFABST233 for inventory and ordering.
  • Needles are generally not included and must be selected separately according to clinician preference and local regulations.

Usage

  • For professional use only: This product is intended exclusively for administration by licensed healthcare or aesthetic professionals in accordance with applicable local laws and professional guidelines.
  • Prior to treatment, perform a full medical history, skin assessment and suitability evaluation; discuss expected outcomes, potential side effects, and obtain informed consent.
  • Cleanse the treatment area thoroughly and disinfect the skin using appropriate antiseptic agents, maintaining strict aseptic technique throughout the procedure.
  • Inject small aliquots of product into the superficial to mid-dermis using a fine needle or suitable cannula, applying appropriate injection techniques (e.g. micro-bolus, nappage, linear threading or point-by-point) depending on the area and clinical protocol.
  • Treat indicated areas such as the face, backs of hands or neck, distributing the product evenly to ensure uniform hydration and improvement in skin quality, taking care to avoid intravascular injection.
  • A typical treatment course involves multiple sessions (for example 2–3 sessions spaced around 3–4 weeks apart), with the exact schedule tailored by the practitioner based on patient needs and response.
  • After each session, gently massage the treated area if required to facilitate even dispersion, avoiding excessive pressure.
  • Advise patients to avoid makeup on the treated area for several hours post-procedure and to avoid intense heat (saunas, steam rooms), vigorous exercise, alcohol, and direct sun exposure for at least 24–48 hours or as per clinic policy.
  • Recommend daily use of a broad-spectrum SPF on treated areas and a supportive skincare routine to help maintain results.
  • Each syringe is single-use for one patient only; discard any remaining product after treatment and dispose of all syringes, needles and sharps in suitable clinical waste containers in line with local regulations.

Contraindications

  • Known hypersensitivity or allergy to hyaluronic acid or any excipients present in the formulation.
  • Active skin infections, inflammatory conditions or lesions in or near the intended injection sites (e.g. active herpes, cellulitis, severe acne, dermatitis).
  • Pregnancy or breastfeeding, as a precaution for elective aesthetic injectable procedures.
  • History of severe allergic reactions or anaphylaxis to injectable aesthetic products or similar skin boosters.
  • Uncontrolled systemic diseases, severe autoimmune conditions or immunocompromised status where elective injectable treatments may be inappropriate unless specifically cleared by a physician.
  • Bleeding disorders or current use of anticoagulant or antiplatelet medications that may significantly increase bleeding or bruising risk, unless carefully evaluated and managed by the treating clinician.
  • Any general contraindication to intradermal or sub-dermal injections, as determined by a qualified healthcare professional.

Adverse Effects

  • Common, usually transient injection-site reactions including redness (erythema), swelling, tenderness, warmth, itching or mild pain; these typically subside within hours to several days.
  • Bruising or small haematomas at injection points due to needle or cannula insertion into superficial blood vessels.
  • Temporary papules, bumps or unevenness in the treated area, which usually resolve as the product integrates and post-injection oedema decreases.
  • Less common local inflammatory reactions such as prolonged swelling, induration or localised nodules that may require observation or treatment by the practitioner.
  • Very rare risk of infection at injection sites if aseptic technique is compromised.
  • As with all injectable hyaluronic acid products, inadvertent intravascular injection or injection under excessive pressure may lead to serious complications (e.g. vascular occlusion); therefore treatment must only be performed by practitioners with appropriate training in facial anatomy, injection techniques and complication management.
  • Patients should be advised to seek immediate medical attention if they experience severe or escalating pain, significant or progressive swelling, skin discolouration, visual disturbance, or other unexpected or concerning symptoms following treatment.

Storage Conditions

  • Store at the temperature range specified on the outer packaging, typically at controlled room temperature; do not freeze.
  • Keep syringes in their original sterile blister and carton to protect from light, contamination and physical damage until use.
  • Do not use the product after the expiry date printed on the packaging.
  • Do not use if the packaging, blister or syringe is damaged, opened or otherwise compromised, as sterility can no longer be guaranteed.
  • Store out of reach of children and unauthorised individuals, in a secure clinical storage area.
  • Once a syringe has been opened and used for a procedure, discard any remaining product; do not attempt to reuse or re-sterilise.

Duration

Typically administered as a course of 2\u20133 treatment sessions at intervals of approximately 3\u20134 weeks, with the exact number and spacing determined by the treating professional according to the patient\u2019s skin condition and goals. Improvements in skin hydration, texture and radiance may last several months; maintenance sessions (for example every 3\u20136 months) can be scheduled as needed to sustain results, based on clinical judgment and patient preference.

Onset

Visible improvements in hydration and glow are often reported within about 48 hours after treatment, with further enhancements in texture, firmness and radiance developing over the following weeks as hydration stabilises and collagen stimulation progresses. Individual response times may vary depending on factors such as age, skin condition and lifestyle.

Browse more Medical Device

Top Treatments

Top Cities in the UK